Cas:210824-69-4 3-bromo-4-methylbenzenesulfonamide manufacturer & supplier

We serve Chemical Name:3-bromo-4-methylbenzenesulfonamide CAS:210824-69-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-bromo-4-methylbenzenesulfonamide

Chemical Name:3-bromo-4-methylbenzenesulfonamide
CAS.NO:210824-69-4
Synonyms:3-bromo-4-methylphenylsulfonic acid amide;2-Brom-toluol-4-sulfonsaeure-amid;2-bromo-toluene-4-sulfonic acid amide;3-Bromo-4-methylbenzenesulphonamide
Molecular Formula:C7H8BrNO2S
Molecular Weight:250.11300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:379ºC at 760mmHg
Density:1.658g/cm3
Index of Refraction:1.599
PSA:68.54000
Exact Mass:248.94600
LogP:3.18600

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-bromo-4-methylphenylsulfonic acid amide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-4-methylbenzenesulphonamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-bromo-4-methylphenylsulfonic acid amide Use and application,2-bromo-toluene-4-sulfonic acid amide technical grade,usp/ep/jp grade.


Related News: The Japanese government plans to limit the administration of AstraZeneca’s vaccines to people aged 40 or over, according to the media. 2-amino-6-hydroxy-4,5-dimethyl-nicotinic acid amide manufacturers J&J’s top brass told the group that its shot holds up against the Delta variant compared with older versions of the virus. After 8 months, the vaccine presents a similar antibody and T-cell response to Delta as it does with other concerning variants, J&J reported. Epigalantamine hydrobromide suppliers CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. (S)-3-Methyl-12-pyridin-3-yl-dodecan-1-ol vendor & factory.